Switzerland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care
Since 2014, Switzerland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care increased 6.9% year on year. With €309.49 Per Capita in 2019, the country was ranked number 2 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care. Liechtenstein ranked the highest with €414.92 Per Capita in 2019, that is +4.3% versus 2018. Belgium recorded the best 5 years average growth at +81.3% per year, while Ireland witnessed the worst performance at -18.1% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 309.49 |
2018 | 301.35 |
2017 | 295.81 |
2016 | 280.30 |
2015 | 267.18 |
Download all data from 2010 to 2019
How does Switzerland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care?
# | 17 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Liechtenstein
|
414.92 | 2019 | +4.3 % | +0.9 % | View data |
2 |
#2
Switzerland
|
309.49 | 2019 | +2.7 % | +6.9 % | View data |
3 |
#3
Austria
|
57.43 | 2019 | -0.2 % | +1.0 % | View data |
4 |
#4
Italy
|
32.67 | 2019 | +0.7 % | +6.9 % | View data |
5 |
#5
United Kingdom
|
15.50 | 2019 | +0.0 % | -2.6 % | View data |